Jason Dedoes, DPM
Foot & Ankle Surgery · Kendallville, INNPI 1851536023
Payments from drug & device makers
Across 15 payments — averaging $346.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osteomed LLC$3K
- Skye Orthobiologics LLC$2K
- Ortho Solutions Inc$243
- Bioventus LLC$155
- In2bones USA, LLC$63
- Linvatec Corporation$26
- plus $31 from 2 others
Across 2 payments — averaging $4500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Skye Orthobiologics LLC$9K
What the payments were for
- Speaking & faculty fees$4,50086%
- Food & beverage$51910%
- Education$1854%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osteomed LLC | 4 | $3,185 |
| Skye Orthobiologics LLC | 1 | $1,500 |
| Ortho Solutions Inc | 4 | $243 |
| Bioventus LLC | 2 | $155 |
| In2bones USA, LLC | 1 | $63 |
| Linvatec Corporation | 1 | $26 |
| Organogenesis Inc. | 1 | $18 |
| Smith+Nephew | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXT-ExtremiLock Ankle$1,622
- EXT-Other$1,500
- EXT-Large Cannulated$1,500
- EXT-Extremilock Foot$1,500
- EXT-Staple$1,500
- EXT-ExtremiFix Midsize/Large$1,500
- OsteoAMP$139
How this compares
$5,204 in reported general payments places this provider in the 55th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 21 | $768 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 97 | $630 |
| Methylprednisolone | 19 | $155 |
| Cephalexin | 26 | $143 |
| Meloxicam | 40 | $111 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $85 |
| Tramadol Hcl | 20 | $69 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Kendallville
- Steven HerbstMuncie$1.6M
- Douglas BlacklidgeKokomo$689K
- Patrick DeheerIndianapolis$493K
- Scott NevilleMooresville$353K
- Travis MontgomeryWestfield$345K
- Robert Clemency IiiSchererville$215K
- William AdamsGreenfield$178K
- Christopher WintersCarmel$158K
- Steven DouthettFort Wayne$153K
- Brian ElliottShelbyville$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.